Page 44 - P4403.14-V110 November OTC Magazine 2025
P. 44

44  GASTRO



                                                  TAKE





                                         ACTION







                                                 AGAINST




                         Up To           HEARTBURN

                        24%
                        POR





















                                      UP TO

                                  24hr


                                   RELIEF                         Product          Size  Buying   RRP  Trade    POR    Pip Code
                                                                                        Price/
                                                                                                  Offer
                                                                                                      %
                                                                                        Single
                                                                                                  %
                                                                  PERRIGO
                                                                   Perrigo Esomeprozole 14s   14  £3.37  £6.99  5%  42% 4188355
                                                                   Perrigo Esomeprozole 7s   7  £1.92  £3.99  6%  42% 4188348
                       UP TO 24HR RELIEF FROM

                      HEARTBURN & ACID REFLUX






                      Perrigo Heartburn and Acid Reflux Control 20 mg Gastro Resistant Capsules (GSL) contain esomeprazole (as magnesium dihydrate). For
                      the short-term treatment of reflux symptoms (e.g. heartburn and acid regurgitation) in adults. Adults 18 years and over: One capsule per day.
                      It may be necessary to take the capsules for 2-3 consecutive days to achieve improvement of symptoms. The duration of treatment is up to 2
                      weeks. Contraindications: known hypersensitivity to esomeprazole, substituted benzimidazoles or to any of the excipients, concomitant use
                      with nelfinavir. Caution: history of gastric ulcer or GI surgery, suspected gastric ulcer or malignancy, jaundice, severe liver disease, or aged over
                      55 years with new or changed symptoms, increased risk of GI infection. Interference with lab tests for neuroendocrine tumours. This medicine
                      contains 0.0018mg benzoic acid in each capsule. Pregnancy and breast-feeding: avoid in pregnancy and do not use during breast-feeding.
                      Interactions: atazanavir, ritonavir, saquinavir, methotrexate, tacrolimus, digoxin, warfarin, phenytoin, citalopram, imipramine, clomipramine,
                      diazepam, clopidogrel. Side effects: hypersensitivity reactions e.g. angioedema & anaphylactic reaction, agranulocytosis, thrombocytopenia,
                      leukopenia,  pancytopenia,  hepatic  failure,  erythema  multiforme,  Stevens-Johnson  syndrome,  toxic  epidermal  necrolysis  (TEN),  subacute
                      cutaneous lupus erythematosus (SCLE), headache, abdominal pain, constipation, diarrhoea, flatulence, nausea, vomiting, fundic gland polyps
                      (benign), bronchospasm. PL 16028/0166. MAH: Galpharm Healthcare Limited, Wrafton, Braunton, Devon, EX33 2DL, UK. Date of preparation:
                      08/2021. RRP (ex. VAT): 7s £4.99,14s £8.99. MAT-9749







                                                                                                                 07/10/2025   17:11:14
         P4403.14-V110 November OTC Magazine 2025.indd   44                                                      07/10/2025   17:11:14
         P4403.14-V110 November OTC Magazine 2025.indd   44
   39   40   41   42   43   44   45   46   47   48   49